Triodos Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Triodos Investment Management's LLY Position: Q2 2026 in Review
Triodos Investment Management increased its Eli Lilly (LLY) stake by 28% in Q2 2026, buying an estimated $7.12M and bringing the position to 32,050 shares worth $38.4M. The position accounts for 2.34% of the portfolio, ranked #17.
Triodos Investment Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Triodos Investment Management held 32,050 shares of Eli Lilly worth $38.4M as of Q2 2026.
- Triodos Investment Management bought 6,970 Eli Lilly shares in Q2 2026, an estimated $7.12M.
- Eli Lilly made up 2.34% of Triodos Investment Management's portfolio in Q2 2026, its #17 holding.
- Triodos Investment Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
- 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Triodos Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.